Intrinsic Value of S&P & Nasdaq Contact Us

DiaMedica Therapeutics Inc. DMAC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.33
+27.4%

DiaMedica Therapeutics Inc. (DMAC) has 12 identified peers for comparison in the Healthcare sector. Peers include CNTA, DAWN, GRTX, HOOK, IKT, IOVA and others.

DMAC has a market capitalization of $352.39M, compared to an average peer market cap of $921.53M. DMAC is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message